Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan

About 4% of the population in Taiwan are seropositive for anti-HCV Ab and 70% with HCV RNA. To address this high chronic hepatitis C disease load, Taiwan National Health Insurance started reimbursing genotype-specific DAAs in 2017 and pangenotype DAAs in mid-2018. With a 97% SVR12 rate, there were s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Chun-Ming, Lin, You-Yu, Liu, Chun-Jen, Lai, Ya-Yun, Yeh, Shiou-Hwei, Yang, Hung-Chih, Kao, Jia-Horng, Hsu, Shih-Jer, Huang, Yi-Hsiang, Yang, Sheng-Shun, Kuo, Hsing-Tao, Cheng, Pin-Nan, Yu, Ming-Lung, Chen, Pei-Jer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621340/
https://www.ncbi.nlm.nih.gov/pubmed/34835100
http://dx.doi.org/10.3390/v13112294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621340/
https://www.ncbi.nlm.nih.gov/pubmed/34835100
http://dx.doi.org/10.3390/v13112294

Ejemplares similares